Editorial Board
- Molecular Cancer Biology Section
- Cancer Immunology and Immunotherapy Section
- Cancer Biomarkers Section
- Cancer Epidemiology and Prevention Section
- Cancer Pathophysiology Section
- Tumor Microenvironment Section
- Cancer Causes, Screening and Diagnosis Section
- Cancer Survivorship and Quality of Life Section
- Cancer Therapy Section
- Clinical Research of Cancer Section
- Systematic Review or Meta-Analysis in Cancer Research Section
- Methods and Technologies Development Section
- Cancer Informatics and Big Data Section
- Pediatric Oncology Section
- Infectious Agents and Cancer Section
- Cancer Drug Development Section
- Cancer Metastasis Section
- Transplant Oncology Section
Please note that the order in which the Editors appear on this page is alphabetical, and follows the structure of the editorial board presented on the MDPI website under information for editors: editorial board responsibilities.
Members
Interests: cancer immunotherapy; targeted therapies; immunomodulation; RNA and CRISPR interferences; phage display
Interests: drug metabolism; cancer diagnoses; metabolomics
Special Issues, Collections and Topics in MDPI journals
2. Division of Solid Tumor Translational Oncology, German Cancer Consortium (DKTK) partner site Essen, German Cancer Research Center (DKFZ), D-69120 Heidelberg, Germany
Interests: translational oncology; pancreatic cancer; tumor biology; imaging/AI; targeted therapy; cancer immunotherapy; epigenetic therapy; treatment resistance
Interests: cancer cachexia; muscle wasting; esophagogastric cancer; surgery; clinical trials
Special Issues, Collections and Topics in MDPI journals
Interests: molecular imaging; theranostics; biomarkers; tracer development
Interests: bionanotechnology; epigenetics; EPS/prostate cancer; MSP/QPCR/TaqMan (Rotor-Gene); DNA sizing (agilent); HPLC; DNA synthesizer; spectrophotometry (nanodrop); clinical trials
Special Issues, Collections and Topics in MDPI journals
2. Department of Neurology, Karolinska University Hospital, 17177 Stockholm, Sweden
3. Institute of Biomedicine, Unit for Infection and Immunology, MediCity Research Laboratory, Turku University, 20520 Turku, Finland
Interests: cytomegalovirus; cancer associated viruses; oncogenic viruses; anti-viral treatment of cancer; biological mechanisms of virus induced cancers
Interests: adult neuro-oncology; diagnosis; treatment; COVID-19
Special Issues, Collections and Topics in MDPI journals
2. Department of Cell Biology, Physiology and Immunology, University of Cordoba, 14004 Córdoba, Spain
Interests: immunosenescence; NK cells; T and NK cell based immunotherapy; cytomegalovirus; leukemia
Special Issues, Collections and Topics in MDPI journals
Interests: gastrointestinal tract cancer; neuroendocrine neoplasms of digestive system; ubiquitin-proteasome system; Crohn disease; Helicobacter pylori pathology
2. Microarrays Unit, Institut de Recerca Contra la Leucèmia Josep Carreras, ICO-Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, 08916 Badalona, Spain
Interests: MDS; MDS/MPN; SNP arrays; cytogenetics; NGS; myeloid neoplasms
Special Issues, Collections and Topics in MDPI journals
Interests: theories of carcinogenesis; role of microenvironment in cancer; control of cell proliferation; theoretical biology and cancer
Interests: molecular diagnostics of childhood tumors; RQ-PCR; WES; RNAseq; MRD; Ig/TCR rearrangements; other target genes
Interests: glioma; glutamate; tumor-associate epilepsy; glia; biophysics
Interests: colorectal cancer; GI cancer; circulating biomarkers-liquid medicine; cancer metabolics; resistance biomarkers
Special Issues, Collections and Topics in MDPI journals
Interests: epigenetics; HDAC inhibitor; molecular-targeting prevention
2. Lymphoma and Myeloma Center Amsterdam - LYMMCARE, and Cancer Center Amsterdam (CCA), Amsterdam, The Netherlands
Interests: B-cell malignancies (diffuse large B-cell lymphoma; mantle cell lymphoma; multiple myeloma; Waldenström's macroglobulinemia; chronic lymphocytic leukemia); target discovery; targeted therapy; signal transduction; tumor microenvironment; cell adhesion and migration; integrins; kinases
Interests: tumor microenviroment; breast cancer; head and neck cancer; radiotherapy; hypoxia; biobanking
Special Issues, Collections and Topics in MDPI journals
2. Department of Oncology, McGill University, Montreal, QC H4A 3T2, Canada
3. Division of Pathology, Department of Laboratory Medicine, McGill University Health Center, Montreal, QC H4A 3J1, Canada
4. Department of Pathology, McGill University, Montreal, QC H3T 1E2, Canada
Interests: melanoma; pathology; X chromosome; cancer; biomarkers
Interests: pancreatic neoplasms; pancreatic cancer; pancreatectomy; pancreatic cysts; gastrointestinal oncology
Interests: RNA-binding proteins in cancer; regulation of RNA turnover; melanoma; neuroblastoma; leukemia
2. Cancer Center at Illinois, University of Illinois, Urbana-Champaign, Urbana, IL 61801, USA
3. Institute of Genomic Biology, University of Illinois, Urbana-Champaign, Urbana, IL 61801, USA
Interests: testicular cancer; cancer therapeutics; chemoresistance; epigenetics; targeted therapy
Special Issues, Collections and Topics in MDPI journals
Interests: antigen presentation by MHC I and MHC II molecules; immune response to cancer; viral immunity and autoimmunity
Interests: human genetics and gene therapy; cancer; curcumin, cisplatin, drug resistance
Interests: gene therapy; T-cell acute lymphoblastic leukemia; Wnt signalling
Interests: primary prevention skin cancer; secondary prevention skin cancer; multidisciplinary management skin cancer
Special Issues, Collections and Topics in MDPI journals
Interests: Ph-negative myeloproliferative neoplasms; cancer-associated thrombosis; multiple myeloma
2. German Cancer Consortium (DKTK), Heidelberg, im Neuenheimer Feld 280, 69120 Heidelberg, Germany
Interests: translational oncology; metastasis research, biomarker identification and analysis; cancer signaling; cancer therapy
Special Issues, Collections and Topics in MDPI journals
Interests: translational cancer research; biomarkers; repurposing; novel drugs
Interests: molecular pathology; molecular diagnostics; IO biomarkers; composite/complex biomarkers; gene fusions; lung cancer